Zenas BioPharma
Latest round
- Series C
Last raised
- May 2024
Total raised
- $318M
Investors
- 20
About Zenas BioPharma
Founded in 2019 by Lonnie Moulder Jr, and based in Massachusetts, US, Zenas BioPharma (USA) LLC operates as a biopharmaceutical company dedicated to developing and delivering immune-based treatments to people. In September 2024, Zenas BioPharma, Inc." BioPharma, Inc.98 million shares of common stock as part of the listing. Following the transaction, Xencor, Inc.2% minority stake, respectively. Zenas BioPharma is a clinical-stage biopharmaceutical company developing and commercializing immunology-based therapies for autoimmune diseases. The company offers a portfolio of therapeutics in clinical development, targeting areas with significant unmet medical needs. Zenas provides transformative treatments to improve the lives of patients with autoimmune conditions.
Who invested in Zenas BioPharma
20 investors across 3 rounds
See all investors in Zenas BioPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zenas BioPharma
Who invested in Zenas BioPharma?
Zenas BioPharma has 20 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zenas BioPharma raised?
Zenas BioPharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Zenas BioPharma last raise money?
Zenas BioPharma's most recent round on record is a Series C, in May 2024.
What does Zenas BioPharma do?
Founded in 2019 by Lonnie Moulder Jr, and based in Massachusetts, US, Zenas BioPharma (USA) LLC operates as a biopharmaceutical company dedicated to developing and delivering immune-based treatments to people.
Where is Zenas BioPharma headquartered?
Zenas BioPharma is headquartered in Waltham, US.
Which VCs invest in companies like Zenas BioPharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Zenas BioPharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Zenas BioPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.